| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |